Stay updated on Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s displayed revision identifier changes from v3.5.2 to v3.5.3, indicating a site/version update rather than a change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-27T07:47:16.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added revision: v3.5.2; removed revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-20T04:54:33.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Release note added for site version v3.5.0 in the record history. The previous version v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-22T09:23:40.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Added a new revision entry for v3.4.3 and removed the v3.4.2 entry in the study record's history.
    Difference
    0.1%
    Check dated 2026-03-08T02:32:49.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added revision entry v3.4.2 and removed v3.4.1 in the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T13:47:41.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The Record History shows a new Revision: v3.4.1 added and Revision: v3.4.0 removed.
    Difference
    0.1%
    Check dated 2026-02-07T08:22:37.000Z thumbnail image

Stay in the know with updates to Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alirocumab on Postprandial Hyperlipemia in Type 2 Diabetes Clinical Trial page.